GeraClinic / NHS cancer waiting times / NHS Bristol, North Somerset And South Gloucestershire ICB / Cancer Screening
NHS Bristol, North Somerset And South Gloucestershire ICB: Cancer Screening — 62-Day Cancer Waits
In April 2026, 61.7% of cancer screening cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days — 47 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Cancer Screening cancer waiting time in NHS Bristol, North Somerset And South Gloucestershire ICB?
As of April 2026, 61.7% of cancer screening cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of referral (29 of 47 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 47 | April 2026 |
| Within 62 days | 29 | Started treatment in time |
| Breaches | 18 | Did not meet 62-day standard |
| 62-day standard met | 61.7% | NHS target: 85% |
| Status vs target | MISSED | Target is 85% |
Other cancer pathways in NHS Bristol, North Somerset And South Gloucestershire ICB
NHS Bristol, North Somerset And South Gloucestershire ICB Screening cancer waits: FAQs
- What is the 62-day cancer waiting time for Cancer Screening in NHS Bristol, North Somerset And South Gloucestershire ICB?
- In April 2026, 61.7% of cancer screening cancer patients in NHS Bristol, North Somerset And South Gloucestershire ICB started treatment within 62 days of referral — covering 47 patients (29 within standard, 18 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Cancer Screening pathway mean?
- The Screening pathway covers patients referred from NHS cancer screening programmes (breast, bowel, cervical). The 62-day clock starts from the date the screening programme refers the patient for further investigation.
- How does NHS Bristol, North Somerset And South Gloucestershire ICB's Screening performance compare to England?
- The England average for the 62-day Cancer Screening pathway was not separately published at England level in the April 2026 extract. NHS Bristol, North Somerset And South Gloucestershire ICB's 61.7% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Bristol, North Somerset And South Gloucestershire ICB for the Cancer Screening pathway in April 2026, there were 18 breaches out of 47 patients.
Screening cancer waits in NHS Bristol, North Somerset And South Gloucestershire ICB — below NHS target
Only 61.7% of cancer screening patients in NHS Bristol, North Somerset And South Gloucestershire ICB met the 62-day standard in April 2026 (target: 85%). GeraClinic can connect you to a UK-registered cancer specialist while you await NHS assessment — your referral is not affected.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.